New

Arkin Holdings

The AI engine Fit Assessment

Beta

Arkin Holdings focuses on pharma/biotech, medical devices, and digital health investments and provides hands-on scientific support (drug development, clinical trials, regulation, and commercialization) to its portfolio, with a $1.5B healthcare portfolio across five investment arms.

Blurb

Arkin Holdings is dedicated to empowering companies that create breakthrough pharma, biotech, medical device, and digital health.

HQ Location

Herzliya (Israel)

Founded

2008

Employees

11 - 50

Total funding raised

Not available

Funding Status

Not available

Arkin Holdings is dedicated to empowering companies that create breakthrough pharma, biotech, medical device, and digital health technologies. Our synergistic healthcare investments are focused on creating innovations that benefit humanity and enhance medical care. We offer extensive experience, with a track record of successful healthcare investments. Experts in the dynamic world of healthcare development, we provide the know-how and close accompaniment that helps our portfolio investments achieve substantial value and growth. Arkin Holdings currently has a healthcare portfolio of $1.5 billion through its 5 investment arms. Its investors include a substantial amount of Israel’s top-tier institutional investors.